Avrobio Inc (AVRO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

ONE KENDALL SQUARE CAMBRIDGE, MA 02139

Avrobio, Inc. operates as a bio-technology company. The Company develops step-change cell and gene therapies for the treatment of cancer and rare disease. Avrobio serves clients in the United States and Canada.

Data based on most recent fiscal year report
Market Cap705.924 Million Shares Outstanding31.67 Million Avg Volume293.808 Thousand
1-Yr BETA vs S&P TR1.248 Current Ratio12.25 Quick Ratio12.25

Are you looking for this stock instead?

View SEC Filings from AVRO instead.

View recent insider trading info

Funds Holding AVRO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVRO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

79.4 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CLARK IAN T

  • Director
1,302 2020-03-25 1

MACKAY GEOFFREY PRESIDENT & CEO

  • Officer
  • Director
0 2020-03-04 5

AVRUCH STEVEN CHIEF LEGAL OFFICER

  • Officer
0 2020-03-04 1

PETERSEN DEANNA M CHIEF BUSINESS OFFICER

  • Officer
151,342 2020-03-04 2

OSTROWSKI ERIK CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-04 1

VOLCK BIRGITTE PRESIDENT OF R&D

  • Officer
0 2020-03-04 1

ATLAS VENTURE ASSOCIATES X, L.P.

  • 10% Owner
3,710,052 2020-02-13 1

PAIGE CHRISTOPHER

  • Director
252,512 2020-02-11 4

BOOTH BRUCE

  • Director
0 2020-01-02 2

ATLAS VENTURE OPPORTUNITY FUND I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

  • SEE REMARKSSEE REMARKSSEE REMARKS
1,100,000 2019-11-18 1

ATLAS VENTURE FUND X, L.P.

ATLAS VENTURE ASSOCIATES X, L.P.

ATLAS VENTURE ASSOCIATES X, LLC

  • 10% Owner
4,756,478 2019-07-19 2

JENKINS ANNALISA

  • Director
33,471 2019-06-13 1

VICKERS PHILIP J.

  • Director
0 2019-06-11 1

DONENBERG PHILLIP B.

  • Director
0 2019-06-11 1

CLARUS LIFESCIENCES III, L.P.

CLARUS VENTURES III GP, L.P.

  • 10% Owner
1,481,162 2019-05-20 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

OSTROWSKI ERIK - Officer CHIEF FINANCIAL OFFICER

2020-03-04 A 100,900 a 100,900 0.00 direct

MACKAY GEOFFREY - Director - Officer PRESIDENT & CEO

2020-03-04 A 292,300 a 292,300 0.00 direct

PETERSEN DEANNA M - Officer CHIEF BUSINESS OFFICER

2020-03-04 A 90,000 a 90,000 0.00 direct

VOLCK BIRGITTE - Officer PRESIDENT OF R&D

2020-03-04 A 76,000 a 76,000 0.00 direct

AVRUCH STEVEN - Officer CHIEF LEGAL OFFICER

2020-03-04 A 90,000 a 90,000 0.00 direct

ATLAS VENTURE ASSOCIATES X, L.P. - > 10% Owner

2020-02-13 J 1,046,426 d 3,710,052 3,710,052.00 direct yes

MACKAY GEOFFREY - Director - Officer SEE REMARKS

2020-02-12 S 1,400 $29.07 d 345,123 490,331.00 direct yes

MACKAY GEOFFREY - Director - Officer SEE REMARKS

2020-02-11 S 44,596 $27.36 d 364,927 491,731.00 direct yes

PAIGE CHRISTOPHER - Director

2020-02-11 S 15,000 $28.00 d 252,512 252,512.00 direct yes

MACKAY GEOFFREY - Director - Officer SEE REMARKS

2020-02-11 S 18,404 $28.10 d 346,523 491,731.00 direct yes

Elevate your investments